TGF-β signaling in aortic aneurysm: another round of controversy

Fuyu Lin; Xiao Yang

doi:10.1016/S1673-8527(09)60078-3

Volume 37 Issue 9

Sep. 2010

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2010 > 37(9): 583-591

PDF( 351 KB)

TGF-β signaling in aortic aneurysm: another round of controversy

doi: 10.1016/S1673-8527(09)60078-3

Fuyu Lin,
Xiao Yang

State Key Laboratory of Proteomics, Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing 100071, China

More Information

Corresponding author: E-mail address: linfuyu2000@yahoo.com.cn (Fuyu Lin); E-mail address: yangx@nic.bmi.ac.cn (Xiao Yang)
Received Date: 2010-04-20
Accepted Date: 2010-06-08
Rev Recd Date: 2010-05-28

Available Online: 2010-10-07

Publish Date: 2010-09-20

Abstract

Abstract

Aortic aneurysm (AA) is a common health problem with high mortality and no effective drugs. Transforming growth factor-β (TGF-β) superfamily members regulate various cellular processes, and TGF-β signaling has key roles in development, tissue homeostasis, and diseases. Interest in the role of TGF-β signaling in the pathogenesis of AAs has recently emerged, particularly since genetic studies demonstrated an association between gene mutations in components of TGF-β signaling and AAs. However, paradoxical discoveries have implicated dysregulated TGF-β signaling in aneurysm formation, complicating the precise functional role for TGF-β in aneurysm development and progression. Furthermore, interventions targeting towards TGF-β signaling using losartan, which may represent a suitable therapeutic option for AAs, were subject to skepticism especially because of conflicting experimental results obtained from TGF-β antibody treatment without knowledge of the underlying mechanism. We propose a TGF-β aneurysm paradox, which would provide a good opportunity for the development of genetic mouse models of AA. These models would be used to clarify the mechanisms underlying TGF-β signaling, which would translate into novel pharmacologic therapies based on the new molecular discoveries.
- aneurysm,
- TGF-β signaling,
- mouse model

FullText(HTML)

References(52)

References

[1]	Arbustini, E., Marziliano, N., Magrassi, L. Aneurysm syndromes and TGF-β receptor mutations N. Engl. J. Med., 355 (2006),p. 2155
[2]	Brooke, B.S., Habashi, J.P., Judge, D.P. et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N. Engl. J. Med., 358 (2008),pp. 2787-2795
[3]	Carta, L., Smaldone, S., Zilberberg, L. et al. J. Biol. Chem., 284 (2009),pp. 5630-5636
[4]	Carvalho, R.L., Itoh, F., Goumans, M.J. et al. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ receptors in mice J. Cell Sci., 120 (2007),pp. 4269-4277
[5]	Charbonneau, N.L., Ono, R.N., Corson, G.M. et al. Fine tuning of growth factor signals depends on fibrillin microfibril networks Birth Defects Res. C Embryo Today, 72 (2004),pp. 37-50
[6]	Chaudhry, S.S., Cain, S.A., Morgan, A. et al. Fibrillin-1 regulates the bioavailability of TGFβ1 J. Cell Biol., 176 (2007),pp. 355-367
[7]	Chen, Q., Chen, H., Zheng, D. et al. Smad7 is required for the development and function of the heart J. Biol. Chem., 284 (2009),pp. 292-300
[8]	Choudhary, B., Zhou, J., Li, P. et al. Absence of TGFβ signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm Genesis, 47 (2009),pp. 115-121
[9]	Daugherty, A., Cassis, L.A. Mouse models of abdominal aortic aneurysms Arterioscler. Thromb. Vasc. Biol., 24 (2004),pp. 429-434
[10]	Daugherty, A., Manning, M.W., Cassis, L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice J. Clin. Invest., 105 (2000),pp. 1605-1612
[11]	Deng, G.G., Martin-McNulty, B., Sukovich, D.A. et al. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm Circ. Res., 92 (2003),pp. 510-517
[12]	Derynck, R., Zhang, Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature, 425 (2003),pp. 577-584
[13]	Dietz, H.C. TGF-β in the pathogenesis and prevention of disease: a matter of aneurysmic proportions J. Clin. Invest., 120 (2010),pp. 403-407
[14]	Dietz, H.C., Cutting, G.R., Pyeritz, R.E. et al. Nature, 352 (1991),pp. 337-339
[15]	Doetschman, T. Influence of genetic background on genetically engineered mouse phenotypes Methods Mol. Biol., 530 (2009),pp. 423-433
[16]	El-Hamamsy, I., Yacoub, M.H. Cellular and molecular mechanisms of thoracic aortic aneurysms Nat. Rev. Cardiol., 6 (2009),pp. 771-786
[17]	Feng, X.H., Derynck, R. Specificity and versatility in TGF-β signaling through Smads Annu. Rev. Cell Dev. Biol., 21 (2005),pp. 659-693
[18]	Frutkin, A.D., Otsuka, G., Stempien-Otero, A. et al. TGF-β1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice Arterioscler. Thromb. Vasc. Biol., 29 (2009),pp. 1251-1257
[19]	Gomez, D., Al Haj Zen, A., Borges, L.F. et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway J. Pathol., 218 (2009),pp. 131-142
[20]	Goumans, M.J., Liu, Z., ten Dijke, P. TGF-β signaling in vascular biology and dysfunction Cell Res., 19 (2009),pp. 116-127
[21]	Goumans, M.J., Mummery, C. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice Int. J. Dev. Biol., 44 (2000),pp. 253-265
[22]	Guo, D.C., Pannu, H., Tran-Fadulu, V. et al. Nat. Genet., 39 (2007),pp. 1488-1493
[23]	Habashi, J.P., Judge, D.P., Holm, T.M. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science, 312 (2006),pp. 117-121
[24]	Hanada, K., Vermeij, M., Garinis, G.A. et al. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice Circ. Res., 100 (2007),pp. 738-746
[25]	Huang, J., Davis, E.C., Chapman, S.L. et al. Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression Circ. Res., 106 (2010),pp. 583-592
[26]	Hynes, R.O. The extracellular matrix: not just pretty fibrils Science, 326 (2009),pp. 1216-1219
[27]	Isogai, Z., Ono, R.N., Ushiro, S. et al. Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein J. Biol. Chem., 278 (2003),pp. 2750-2757
[28]	Jones, J.A, Spinale, F.G., Ikonomidis, J.S. Transforming growth factor-β signaling in thoracic aortic aneurysm development: a paradox in pathogenesis J. Vasc. Res., 46 (2009),pp. 119-137
[29]	Lan, Y., Liu, B., Yao, H. et al. Essential role of endothelial Smad4 in vascular remodeling and integrity Mol. Cell Biol., 27 (2007),pp. 7683-7692
[30]	Loeys, B., De Paepe, A. New insights in the pathogenesis of aortic aneurysms Verh. K. Acad. Geneeskd. Belg., 70 (2008),pp. 69-84
[31]	Loeys, B.L., Chen, J., Neptune, E.R. et al. Nat. Genet., 37 (2005),pp. 275-281
[32]	Loeys, B.L., Schwarze, U., Holm, T. et al. Aneurysm syndromes caused by mutations in the TGF-β receptor N. Engl. J. Med., 355 (2006),pp. 788-798
[33]	Matt, P., Habashi, J., Carrel, T. et al. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J. Thorac. Cardiovasc. Surg., 135 (2008),pp. 389-394
[34]	McLaughlin, P.J., Chen, Q., Horiguchi, M. et al. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice Mol. Cell Biol., 26 (2006),pp. 1700-1709
[35]	Milewicz, D.M., Guo, D.C., Tran-Fadulu, V. et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction Annu. Rev. Genomics Hum. Genet., 9 (2008),pp. 283-302
[36]	Mizuguchi, T., Collod-Beroud, G., Akiyama, T. et al. Nat. Genet., 36 (2004),pp. 855-860
[37]	Moustakas, A., Souchelnytskyi, S., Heldin, C.H. Smad regulation in TGF-β signal transduction J. Cell Sci., 114 (2001),pp. 4359-4369
[38]	Neptune, E.R., Frischmeyer, P.A., Arking, D.E. et al. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome Nat. Genet., 33 (2003),pp. 407-411
[39]	Owens, G.K., Kumar, M.S., Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiol. Rev., 84 (2004),pp. 767-801
[40]	Pannu, H., Fadulu, V.T., Chang, J. et al. Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections Circulation, 112 (2005),pp. 513-520
[41]	Pannu, H., Tran-Fadulu, V., Papke, C.L. et al. Hum. Mol. Genet., 16 (2007),pp. 2453-2462
[42]	Park, S.O., Lee, Y.J., Seki, T. et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 Blood, 111 (2008),pp. 633-642
[43]	Rodríguez-Vita, J., Sánchez-López, E., Esteban, V. et al. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism Circulation, 111 (2005),pp. 2509-2517
[44]	Ruiz-Ortega, M., Rodríguez-Vita, J., Sanchez-Lopez, E. et al. TGF-β signaling in vascular fibrosis Cardiovasc. Res., 74 (2007),pp. 196-206
[45]	Tang, Y., Lee, K.S., Yang, H. et al. Genomics, 85 (2005),pp. 60-70
[46]	ten Dijke, P., Arthur, H.M. Extracellular control of TGFβ signaling in vascular development and disease Nat. Rev. Mol. Cell Biol., 8 (2007),pp. 857-869
[47]	Tian, M., Schiemann, W.P. The TGF-β paradox in human cancer: an update Future Oncol., 5 (2009),pp. 259-271
[48]	Vorp, D.A., Vande Geest, J.P. Biomechanical determinants of abdominal aortic aneurysm rupture Aterioscler. Thromb. Vasc. Biol., 25 (2005),pp. 1558-1566
[49]	Wang, W., Huang, X.R., Canlas, E. et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis Circ. Res., 98 (2006),pp. 1032-1039
[50]	Wang, Y., Ait-Oufella, H., Herbin, O. et al. TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice J. Clin. Invest., 120 (2010),pp. 422-432
[51]	Zeller, J.L., Burke, A.E., Glass, R.M. JAMA patient page. Aortic aneurysms JAMA, 302 (2009),p. 2050
[52]	Zhu, L., Vranckx, R., Khau Van Kien, P. et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus Nat. Genet., 38 (2006),pp. 343-349